fig7

Cordycepin alleviates oxaliplatin-induced fatty liver disease

Figure 7. Non-targeted Metabolomics Analysis of Hepatic Tissues from Control, OXA, and OCordy Mouse Groups. (A and B) Heatmaps showing clustering analysis of the top 30 DMs in liver tissues from OXA-control (A) and OCordy-OXA (B) comparisons. Color intensity represents metabolite abundance (red: upregulated; blue: downregulated), revealing significant metabolic alterations and distinct clustering patterns. (C and D) VIP bar plots displaying expression levels of the top 30 differentially expressed metabolites in OXA-Control (C) and OCordy-OXA (D) comparisons in liver tissues. X-axis: VIP values; Y-axis: metabolites (red: upregulated; blue: downregulated). OXA: Oxaliplatin; OCordy: Oxaliplatin plus cordycepin; DMs: differential metabolites.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/